Cargando…

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies

For many thoracic malignancies, surgery, when feasible, is the preferred upfront modality for local control. However, adjuvant radiation plays an important role in minimizing the risk of locoregional recurrence. Tumors in the thoracic category include certain subgroups of non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez, Daniel R., Komaki, Ritsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712677/ https://www.ncbi.nlm.nih.gov/pubmed/24213242 http://dx.doi.org/10.3390/cancers4010307

Ejemplares similares

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

The Potential Role of Respiratory Motion Management and Image Guidance in the Reduction of Severe Toxicities Following Stereotactic Ablative Radiation Therapy for Patients with Centrally Located Early Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2014)

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer
por: Yue, Jinbo, et al.
Publicado: (2017)

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer
por: Park, Jaehyeon, et al.
Publicado: (2014)

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2011)

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial
por: Zhu, Zhengfei, et al.
Publicado: (2014)

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy
por: Xiang, Zuo-Lin, et al.
Publicado: (2012)

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2011)

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer
por: Sulman, Erik P, et al.
Publicado: (2009)

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer
por: Moreno, Amy C., et al.
Publicado: (2018)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Treatment of Brain Metastasis from Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2010)

Salvage radiation therapy for postoperative locoregionally recurrent non-small cell lung cancer: a single-center experience
por: Jo, Yoon Young, et al.
Publicado: (2021)

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2010)

Stereotactic body radiation therapy for non-small cell lung cancer: A review
por: Prezzano, Kavitha M, et al.
Publicado: (2019)

Radiation Therapy in Extensive Stage Small Cell Lung Cancer
por: Jeremic, Branislav, et al.
Publicado: (2017)

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2018)

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor?
por: Oh, Dongryul, et al.
Publicado: (2012)

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

Deep Learning Improved Clinical Target Volume Contouring Quality and Efficiency for Postoperative Radiation Therapy in Non-small Cell Lung Cancer
por: Bi, Nan, et al.
Publicado: (2019)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020)

MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer
por: Li, Rong, et al.
Publicado: (2016)

The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer
por: Vivekanandan, S., et al.
Publicado: (2017)

AB013. Treatment of thymic oligometastastic or oligoprogressive lesions with hypofractionated radiation therapy or stereotactic body radiation therapy
por: Jackson, Christopher B., et al.
Publicado: (2022)

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Billing, David L., et al.
Publicado: (2021)

The Place and the Role of Radiation Therapy in the Treatment of Thymic Carcinoma
por: Pinelopi-Theopisti, Memtsa, et al.
Publicado: (2016)

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer
por: Sepesi, Boris, et al.
Publicado: (2020)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023)

Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Santos, Patricia Mae G., et al.
Publicado: (2022)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

Radiation exposure triggers the malignancy of non-small cell lung cancer cells through the activation of visfatin/Snail signaling
por: Xiao, Liang, et al.
Publicado: (2021)

A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
por: Cho, Eun Na, et al.
Publicado: (2015)

Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non–Small Cell Lung Cancer
por: Yu, Brian, et al.
Publicado: (2022)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Radiation dose for thymic tumours
por: Lalani, Nafisha, et al.
Publicado: (2020)

Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer
por: Hoppen, Lea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dbql7f3siuisadp72fd75adiil